Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.
about
Multimodality treatment strategies have changed prognosis of peritoneal metastasesSecond-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genesAdjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC.Patients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of second look laparotomyCytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal CancerThe role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC).Systematic review and meta-analysis of intraoperative peritoneal lavage for colorectal cancer staging.Role of peritoneal lavage cytology and prediction of prognosis and peritoneal recurrence after curative surgery for colorectal cancer.Ninety percent of the adverse outcomes occur in 10% of patients: can we identify the populations at high risk of developing peritoneal metastases after curative surgery for colorectal cancer?A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC.Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer.Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decadesPrinciples and Innovations in Peritoneal Surface Malignancy Treatment.Peritoneal carcinomatosis
P2860
Q26769938-82E78CEA-CA07-40A6-AA6F-8148E6DB10E5Q28574018-4353FCE7-30C0-4B93-8E2A-3F6A88C0E4F2Q34477640-153A406F-269A-45A3-AD48-3EA79824AD47Q35974935-F463C861-6562-4961-BC5A-D4D1E61CDAB3Q36646562-F1DCB75D-48EF-4C64-BB19-4C3ED6457F93Q36758936-BC0BD4DF-EB2E-4926-81F8-4D971AE42287Q38027027-CC4E7B27-F646-471E-BDCF-F1CCA012C1CEQ38093804-53F0D042-240D-4F40-AE91-7C22918997E4Q38429774-CED568F1-16DE-4557-9254-E5FF5588B1D5Q38765795-CDE530D4-E704-478D-B49E-7C8BACE4C404Q38836835-A2074EE4-EA65-4716-89F6-21BE7EF27E2FQ39406537-61523167-ABAF-4622-B45B-1F7FCF158779Q39922489-A3B1D20A-8523-486F-942E-4C8CF4D0AB98Q47166165-C4FBD9C7-0160-4B9F-9E3F-F70C7DB27EC9Q58766340-2A0CD26E-D29D-4FA6-AEFB-EF384247574D
P2860
Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prospective randomized trial e ...... orectal peritoneal metastases.
@ast
Prospective randomized trial e ...... orectal peritoneal metastases.
@en
type
label
Prospective randomized trial e ...... orectal peritoneal metastases.
@ast
Prospective randomized trial e ...... orectal peritoneal metastases.
@en
prefLabel
Prospective randomized trial e ...... orectal peritoneal metastases.
@ast
Prospective randomized trial e ...... orectal peritoneal metastases.
@en
P2093
P2860
P356
P1433
P1476
Prospective randomized trial e ...... orectal peritoneal metastases.
@en
P2093
Clinton D Kemp
Itzhak Avital
Jeremy L Davis
Mary Ann Toomey
Robert T Ripley
Seth M Steinberg
P2860
P2888
P356
10.1186/1745-6215-11-62
P577
2010-05-25T00:00:00Z
P5875
P6179
1023703611